Latest filing published 16 Sept 2026 for Puma Biotechnology, INC., €126k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alessandra Cesano: trading record in brief
All filings by Alessandra Cesano on record concern Puma Biotechnology, Inc. Over a trading history stretching from 13 June 2023 to 14 September 2026, the count stands at 8 filings.
No open-market purchase appears, only 3 sales worth €603k. Besides market trades, the filings include 4 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.
Most recently, on 16 September 2026, the filings show an option exercise worth €126k in Puma Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alessandra Cesano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$2.93Common StockSEC:0001437749-26-030593:0
- 62,150 shares@ US$9.123Common StockSEC:0001437749-26-030593:1
- 27,000 sharesCommon StockSEC:0001437749-26-020702:0
- 27,000 shares@ US$3.367100.0% of flowCommon StockSEC:0001437749-25-023268:0
- 12,150 shares@ US$3.4031.3% of flowCommon StockSEC:0001437749-25-020711:0
- 27,000 shares0Common StockSEC:0001437749-25-020357:0
- 27,000 shares0Common StockSEC:0001437749-24-021012:0
- 27,000 shares0Common StockSEC:0001437749-23-017590:0
8 of 8 declarations
